| Aug 7 |
Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
|
| Aug 7 |
EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4
|
| Jul 31 |
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
|
| Jul 23 |
Crude Oil Down 2%; GE Aerospace Earnings Top Views
|
| Jul 23 |
US Stocks Edge Higher; General Motors Posts Upbeat Earnings
|
| Jul 23 |
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
|
| Jul 23 |
EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder
|
| Jun 20 |
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
|
| Jun 20 |
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
|
| Jun 6 |
MicroCap Rodeo’s Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
|
